220 related articles for article (PubMed ID: 11402090)
1. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
[TBL] [Abstract][Full Text] [Related]
2. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
Miyata T; Sugiyama S; Saito A; Kurokawa K
Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation in uraemic toxicity.
van Ypersele de Strihou C
EDTNA ERCA J; 2003; 29(3):148-50. PubMed ID: 14552090
[TBL] [Abstract][Full Text] [Related]
4. 'Carbonyl stress' and dialysis-related amyloidosis.
Miyata T; Ueda Y; Saito A; Kurokawa K
Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
[TBL] [Abstract][Full Text] [Related]
5. Relevance of oxidative and carbonyl stress to long-term uremic complications.
Miyata T; Kurokawa K; van Ypersele de Strihou C
Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
[TBL] [Abstract][Full Text] [Related]
6. Implication of carbonyl stress in long-term uraemic complications.
Wada T; Miyata T; Kurokawa K
Nephrol Dial Transplant; 1999; 14 Suppl 1():79-81. PubMed ID: 10048461
[TBL] [Abstract][Full Text] [Related]
7. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
Miyata T
Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
9. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
Sugiyama S; Miyata T; Inagi R; Kurokawa K
Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
[TBL] [Abstract][Full Text] [Related]
10. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2000; 15 Suppl 2():7-11. PubMed ID: 11051031
[TBL] [Abstract][Full Text] [Related]
11. Reactive carbonyl compounds as uremic toxins.
Miyata T; Akhand AA; Kurokawa K; Nakashima I
Contrib Nephrol; 2001; (133):71-80. PubMed ID: 11477755
[No Abstract] [Full Text] [Related]
12. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.
Miyata T; Kurokawa K; VAN Ypersele DE Strihou C
J Am Soc Nephrol; 2000 Sep; 11(9):1744-1752. PubMed ID: 10966500
[No Abstract] [Full Text] [Related]
13. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
Miyata T; Izuhara Y; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products in uremia.
Henle T; Miyata T
Adv Ren Replace Ther; 2003 Oct; 10(4):321-31. PubMed ID: 14681861
[TBL] [Abstract][Full Text] [Related]
16. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.
Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of the oxidative stress and its implication in uremia and dialysis.
Galli F; Canestrari F; Bellomo G
Contrib Nephrol; 1999; 127():1-31. PubMed ID: 10629773
[No Abstract] [Full Text] [Related]
18. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes.
Dolhofer-Bliesener R; Lechner B; Gerbitz KD
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):355-61. PubMed ID: 8704053
[TBL] [Abstract][Full Text] [Related]
19. Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients.
Kalousová M; Zima T; Tesar V; Sulková S; Fialová L
Kidney Int Suppl; 2003 May; (84):S62-4. PubMed ID: 12694311
[TBL] [Abstract][Full Text] [Related]
20. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
Niwa T
Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
